Indeed, using our conditional NPM/ALK lymphoma transgenic mouse model [46,47], we observed that ALK works alongside HIF1α to boost VEGF (Vascular endothelial growth factor) expression by down-regulating miR-16, an inhibitor of VEGF mRNA [38]. The gene discussed is ALK; the disease is lymphoma.